	US 12,285,461 B2
	Topical antibiotic
Tony LaRosa, Woodland Hills, CA (US); Robert Davidson, Woodland Hills, CA (US); and David Reid, Woodland Hills, CA (US)
Filed by Concept Matrix Solutions, Newbury park, CA (US)
Filed on Mar. 20, 2023, as Appl. No. 18/186,639.
Application 18/186,639 is a continuation of application No. 16/946,990, filed on Jul. 14, 2020, granted, now 11,607,442, issued on Mar. 21, 2023.
Claims priority of provisional application 62/978,345, filed on Feb. 19, 2020.
Claims priority of provisional application 62/907,754, filed on Sep. 30, 2019.
Prior Publication US 2023/0226144 A1, Jul. 20, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/05 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 31/65 (2006.01); A61K 31/702 (2006.01); A61K 38/12 (2006.01); A61K 45/06 (2006.01); A61K 47/06 (2006.01)

CPC A61K 38/12 (2013.01) [A61K 9/0014 (2013.01); A61K 9/06 (2013.01); A61K 31/05 (2013.01); A61K 31/65 (2013.01); A61K 31/702 (2013.01); A61K 45/06 (2013.01); A61K 47/06 (2013.01)]

13 Claims

1. A method of first aid to prevent bacterial infection due to at least one of minor cuts, scrapes, and burns, the method comprising topically administering to affected areas of a subject in need thereof a topical antibiotic ointment comprising:

(a) bacitracin zinc;

(b) cannabidiol (CBD); and

wherein the CBD is present as a CBD isolate, dissolved or dispersed in hemp extract.